PEAK6 Investments’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
FLAM
DSCM
AIC
SM
RHJA
GIPM
PEAK6 Investments's OPRX Position: Q4 2023 in Review
PEAK6 Investments sold out of OptimizeRx (OPRX) in Q4 2023, closing a stake of 5,925 shares — an estimated $56.9K sold.
PEAK6 Investments first reported a position in OPRX in Q3 2019 and held it in 10 quarters. The position peaked at $3.37M in Q1 2022. 98 funds tracked by Wall St. Rank hold OPRX as of Q4 2023.
- PEAK6 Investments reported no remaining OptimizeRx position as of Q4 2023 after selling out during the quarter.
- PEAK6 Investments sold 5,925 OptimizeRx shares in Q4 2023, an estimated $56.9K.
- PEAK6 Investments first reported a position in OptimizeRx in Q3 2019 and held it in 10 quarters.
- PEAK6 Investments's OptimizeRx position peaked at $3.37M in Q1 2022.
- 98 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2023.
Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.